Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis
Article in Clinical Infectious Diseases (March 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in Clinical Infectious Diseases (March 2024)
Article in Infectious Diseases (February 2024)
Article in Nanoscale Advances (December 2023)